Immune Therapeutics Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.02 |
Market Cap |
$2.67 M |
Shares Outstanding |
445.58 M |
Public Float |
385.48 M |
Address |
37 North Orange Avenue Orlando Florida 32801 United States |
Employees | - |
Website | http://www.immunetherapeutics.com |
Updated | 07/08/2019 |
Immune Therapeutics, Inc. is a biopharmaceutical company focuses on the commercialization of affordable non-toxic immunotherapies focused on the activation and rebalancing of the body's immune system. It specializes in the treatment of cancers, HIV, autoimmune diseases, inflammatory conditions, and other opportunistic infections for chronic often life-threatening diseases through the mobilization of the body's immune system in emerging nations using existing clinical data. The company was founded by Noreen Griffin on December 2, 1993 and is headquartered in Orlando, FL. |